Evidence map›Paper›PMID 34675309›Full record

ArticleScientific reports2021

Modulation of the N13 component of the somatosensory evoked potentials in an experimental model of central sensitization in humans.

A Di Lionardo, G Di Stefano, C Leone, G Di Pietro, E Sgro, E Malara, C Cosentino, C Mollica, A J Blockeel, O Caspani and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Central neuropathic pain.Nature reviews. Disease primers · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 6 countries.

A Di Lionardo *Department of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy.
G Di Stefano *Department of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy.
C LeoneDepartment of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy.
G Di PietroDepartment of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy.
E SgroDepartment of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy.
E MalaraDepartment of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy.
C CosentinoDepartment of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy.
C MollicaDepartment of Statistical Sciences, Sapienza University, Rome, Italy.
A J BlockeelSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
O CaspaniDepartment of Neurophysiology, Mannheim Center for Translational Neurosciences (MCTN), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
L Garcia-LarreaLyon Neurosciences Center Research Unit Inserm U 1028, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Lyon 1 University, Lyon, France.
A MourauxUCLouvain, Institute of Neuroscience (IoNS), Brussels, Belgium.
R D TreedeDepartment of Neurophysiology, Mannheim Center for Translational Neurosciences (MCTN), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
K G PhillipsNeuroscience Next Generation Therapeutics, Eli Lilly and Company, Lilly Innovation Center, Cambridge, MA, 02142, USA.
M ValerianiDepartment of Neuroscience, Headache Center, Bambino Gesù Children's Hospital, Rome, Italy.
Andrea TruiniDepartment of Human Neuroscience, University Sapienza, Viale Università 30, 00185, Rome, Italy. andrea.truini@uniroma1.it.
Sapienza University of Rome · ITBambino Gesù Children's Hospital · ITBernstein Center for Computational Neuroscience Heidelberg-Mannheim · DEEli Lilly (United States) · USHeidelberg University · DEHospices Civils de Lyon · FRUniversity of Bristol · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The N13 component of somatosensory evoked potential (N13 SEP) represents the segmental response of dorsal horn neurons. In this neurophysiological study, we aimed to verify whether N13 SEP might reflect excitability changes of dorsal horn neurons during central sensitization. In 22 healthy participants, we investigated how central sensitization induced by application of topical capsaicin to the ulnar nerve territory of the hand dorsum modulated N13 SEP elicited by ulnar nerve stimulation. Using a double-blind placebo-controlled crossover design, we also tested whether pregabalin, an analgesic drug with proven efficacy on the dorsal horn, influenced capsaicin-induced N13 SEP modulation. Topical application of capsaicin produced an area of secondary mechanical hyperalgesia, a sign of central sensitization, and increased the N13 SEP amplitude but not the peripheral N9 nor the cortical N20-P25 amplitude. This increase in N13 SEP amplitude paralleled the mechanical hyperalgesia and persisted for 120 min. Pregabalin prevented the N13 SEP modulation associated with capsaicin-induced central sensitization, whereas capsaicin application still increased N13 SEP amplitude in the placebo treatment session. Our neurophysiological study showed that capsaicin application specifically modulates N13 SEP and that this modulation is prevented by pregabalin, thus suggesting that N13 SEP may reflect changes in dorsal horn excitability and represent a useful biomarker of central sensitization in human studies.

Indexed as

Central Nervous System SensitizationEvoked Potentials, SomatosensoryAdultCapsaicinDouble-Blind MethodFemaleHumansHyperalgesiaMaleSensory System AgentsYoung AdultCapsaicinSensory System Agents

Identifiers

PMID34675309
PMCPMC8531029
OpenAlexW3206350525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.